Barclays
BHC icon

Barclays’s Bausch Health BHC Stock Holding History

Barclays’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.16M Buy
+400,000
New +$2.39M ﹤0.01% 2313
2022
Q1 		– Sell
-290,500
Closed -$8.02M – 4964
2021
Q4 		$8.02M Buy
290,500
+277,900
+2,206% +$7.44M ﹤0.01% 1398
2021
Q3 		$351K Hold
12,600
– – ﹤0.01% 3355
2021
Q2 		$369K Hold
12,600
– – ﹤0.01% 3244
2021
Q1 		$400K Sell
12,600
-1,200
-9% -$35.2K ﹤0.01% 3313
2020
Q4 		$287K Hold
13,800
– – ﹤0.01% 3566
2020
Q3 		$214K Sell
13,800
-6,500
-32% -$112K ﹤0.01% 3801
2020
Q2 		$371K Sell
20,300
-181,300
-90% -$3.19M ﹤0.01% 3586
2020
Q1 		$3.13M Sell
201,600
-50,800
-20% -$1.22M ﹤0.01% 1877
2019
Q4 		$7.55M Buy
252,400
+47,200
+23% +$1.23M ﹤0.01% 1612
2019
Q3 		$4.48M Sell
205,200
-22,000
-10% -$503K ﹤0.01% 1957
2019
Q2 		$5.74M Buy
227,200
+104,100
+85% +$2.47M ﹤0.01% 1745
2019
Q1 		$3.04M Sell
123,100
-444,300
-78% -$10.6M ﹤0.01% 2130
2018
Q4 		$10.5M Sell
567,400
-93,000
-14% -$2.21M 0.01% 1131
2018
Q3 		$17M Sell
660,400
-175,800
-21% -$4.03M 0.01% 947
2018
Q2 		$19.4M Sell
836,200
-2,679,300
-76% -$55.4M 0.02% 797
2018
Q1 		$56M Sell
3,515,500
-1,392,100
-28% -$25.9M 0.04% 383
2017
Q4 		$102M Buy
4,907,600
+1,519,400
+45% +$24.1M 0.08% 198
2017
Q3 		$48.6M Buy
3,388,200
+1,757,100
+108% +$26.6M 0.05% 302
2017
Q2 		$28.2M Buy
1,631,100
+969,900
+147% +$11.6M 0.03% 456
2017
Q1 		$7.29M Sell
661,200
-4,479,900
-87% -$61.6M 0.01% 1083
2016
Q4 		$74.7M Buy
5,141,100
+489,700
+11% +$8.98M 0.08% 191
2016
Q3 		$114M Sell
4,651,400
-189,800
-4% -$4.91M 0.13% 121
2016
Q2 		$97.5M Buy
4,841,200
+300,300
+7% +$8.5M 0.13% 128
2016
Q1 		$118M Buy
4,540,900
+571,900
+14% +$42.3M 0.18% 89
2015
Q4 		$401M Sell
3,969,000
-368,600
-8% -$41.4M 0.49% 28
2015
Q3 		$772M Sell
4,337,600
-173,300
-4% -$40.4M 0.93% 12
2015
Q2 		$1B Sell
4,510,900
-2,082,800
-32% -$462M 1.12% 5
2015
Q1 		$1.31B Buy
6,593,700
+1,416,600
+27% +$251M 1.51% 5
2014
Q4 		$740M Buy
5,177,100
+1,120,400
+28% +$151M 0.71% 13
2014
Q3 		$531M Buy
4,056,700
+1,324,800
+48% +$158M 0.51% 21
2014
Q2 		$344M Buy
2,731,900
+1,391,600
+104% +$178M 0.36% 36
2014
Q1 		$176M Sell
1,340,300
-17,200
-1% -$2.35M 0.2% 78
2013
Q4 		$159M Buy
1,357,500
+487,000
+56% +$53.4M 0.16% 83
2013
Q3 		$90.5M Sell
870,500
-22,700
-3% -$2.21M 0.11% 140
2013
Q2 		$76.9M Buy
+893,200
New +$70.4M 0.1% 161

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's BHC Position: Q1 2026 in Review

Barclays increased its Bausch Health (BHC) stake by 520% in Q1 2026, buying an estimated $621K and bringing the position to 123,783 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Barclays first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.24B in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Barclays held 123,783 shares of Bausch Health worth $668K as of Q1 2026.
  • Barclays bought 103,818 Bausch Health shares in Q1 2026, an estimated $621K.
  • Bausch Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3003 holding.
  • Barclays first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Bausch Health position peaked at $1.24B in Q4 2014.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.